Position | Company | Period |
---|---|---|
Chief Executive Officer, Director | Avadel Pharmaceuticals PLC | June 22, 2012 - Dec. 30, 2018 |
Chief Executive Officer | Avadel Pharmaceuticals PLC | March 13, 2012 - June 22, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2018-08-14 | 2018-08-10 |
Avadel Pharmaceuticals PLC
(AVDL)
|
S Sale |
16,297
-6.1%
4.9179,953 USD |
16,297 -6.1% | 4.91 | 79,953 USD | |
2018-06-27 | 2018-06-26 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
2,500
+1.0%
6.0415,100 USD |
2,500 +1.0% | 6.04 | 15,100 USD | |
2016-09-07 | 2016-09-02 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
2,000
+1.1%
14.1228,240 USD |
2,000 +1.1% | 14.12 | 28,240 USD | |
2016-05-16 | 2016-05-12 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
5,000
+3.9%
8.8444,200 USD |
5,000 +3.9% | 8.84 | 44,200 USD | |
2016-03-21 | 2016-03-18 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
5,000
+4.0%
11.0455,220 USD |
5,000 +4.0% | 11.04 | 55,220 USD | |
2016-03-16 | 2016-03-14 |
Avadel Pharmaceuticals PLC
(AVDL)
|
B Purchase |
10,000
+8.8%
9.7497,350 USD |
10,000 +8.8% | 9.74 | 97,350 USD |